Choreo LLC Takes $230,000 Position in Verona Pharma plc (NASDAQ:VRNA)
Choreo LLC bought a new position in Verona Pharma plc (NASDAQ:VRNA – Free Report) during the 4th quarter, according to the ...
Verona Pharma (NASDAQ:VRNA) Price Target Raised to $72.00
Verona Pharma (NASDAQ:VRNA – Free Report) had its price target hoisted by Canaccord Genuity Group from $44.00 to $72.00 in a research note published on Wednesday,Benzinga reports. They currently have ...
Managed Healthcare Executive8h
More Results for Nerandomilast Reported by BI, This Time for Progressive Pulmonary Fibrosis
Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim reported positive results from a similar phase 3 trial assessing its PDE4B ...